NRT pharmacotherapy algorithm references

  1. Shiffman S, Elash CA, Paton SM, Gwaltney CJ, Paty JA, Clark DB, et al. Comparative efficacy of 24-hour and 16-hour transdermal nicotine patches for relief of morning craving. Addiction. 2000;95(8):1185-95. 

  2. Fant RV, Owen LL, Henningfield JE. Nicotine replacement therapy. Prim Care. 1999;26(3):633-52. 

  3. Royal Australian College of General Practitioners. Supporting smoking cessation: a guide for health professionals. Second Edition. Melbourne: RACGP; 2019.  

  4. Lindson N, Chepkin SC, Ye W, Fanshawe TR, Bullen C, Hartmann-Boyce J. Different doses, durations and modes of delivery of nicotine replacement therapy for smoking cessation. Cochrane Database Syst Rev. 2019;4(4):CD013308. 

  5. Hansson A, Hajek P, Perfekt R, Kraiczi H. Effects of nicotine mouth spray on urges to smoke, a randomised clinical trial. BMJ Open. 2012;2(5). 

  6. Kraiczi H, Hansson A, Perfekt R. Single-dose pharmacokinetics of nicotine when given with a novel mouth spray for nicotine replacement therapy. Nicotine Tob Res. 2011;13(12):1176-82. 

  7. Tønnesen P, Lauri H, Perfekt R, Mann K, Batra A. Efficacy of a nicotine mouth spray in smoking cessation: a randomised, double-blind trial. Eur Respir J. 2012 Sep;40(3):548-54. doi: 10.1183/09031936.00155811. Epub 2012 Feb 9. PMID: 22323576; PMCID: PMC3432241. 

  8. Henningfield JE, Fant RV, Buchhalter AR, Stitzer ML. Pharmacotherapy for nicotine dependence. CA Cancer J Clin. 2005 Sep-Oct;55(5):281-99; quiz 322-3, 325. doi: 10.3322/canjclin.55.5.281. PMID: 16166074. 

  9. Lindson N, Chepkin SC, Ye W, Fanshawe TR, Bullen C, Hartmann-Boyce J. Different doses, durations and modes of delivery of nicotine replacement therapy for smoking cessation. Cochrane Database Syst Rev. 2019;4(4):CD013308. 

  10. NPS Medicinewise. Nicotine Patch QuitX for smoking cessation. 2013. https://www.nps.org.au/medicine-finder/quit-x-patches  

  11. NPS Medicinewise. Nicotine Patch for smoking cessation. 2013. https://www.nps.org.au/radar/articles/nicotine-patches-nicabate-p-nicorette-nicotinell-step-1-for-smoking-cessation#r7 

  12. Fant RV, Henningfield JE, Shiffman S, Strahs KR, Reitberg DP. A pharmacokinetic crossover study to compare the absorption characteristics of three transdermal nicotine patches. Pharmacol Biochem Behav. 2000 Nov;67(3):479-82. doi: 10.1016/s0091-3057(00)00399-3. PMID: 11164075. 

  13. GlaxoSmithKline Consumer Healthcare. Nicabate clear patch, nicabate pre-quit and nicabate p rate-controlled nicotine transdermal patches. [product information]. Ermington, NSW: GlaxoSmithKline Australia Pty Ltd; April 2020. https://medicines.org.au/product-information/document/Nicabate_Patch_GC_PI 

  14. Pharmaceutical Society of Australia. Guidelines for pharmacists providing smoking cessation support: Pharmaceutical Society of Australia Ltd; 2021. Available from:  https://my.psa.org.au/servlet/fileField?entityId=ka10o000000U2cWAAS&field=PDF_File_Member_Content__Body__s 

  15. Fagerström K. Time to first cigarette; the best single indicator of tobacco dependence? Monaldi Arch Chest Dis. 2003;59(1):91-4. 

  16. Johnson & Johnson Pacific Nicorette Inhalator [Product Information]. April 2019.  

  17. Australian Medicines Handbook. Adelaide: Australian Medicines Handbook Pty Ltd; 2020. 

  18. Stead LF, Perera R, Bullen C, et al. Nicotine replacement therapy for smoking cessation. Cochrane Database Syst Rev. 2012;11:CD000146.